-

Agilent Receives Two Scientists’ Choice Awards

Innovative instruments receive top honors from members of SelectScience

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product, and the Agilent InfinityLab LC/MSD iQ system won for Best New Spectroscopy Product.

SelectScience, an independent, expert-led scientific review, began the Scientists’ Choice Awards in 2007 to enable scientists to voice their opinions on the best laboratory products. Each year, SelectScience invites members to nominate their favorite products in various categories. The awards are based on member votes and recognize the innovation and impact these products have had on the market.

“We are delighted to have received these awards,” said Jacob Thaysen, senior vice president, Agilent and President, Life Sciences and Applied Markets Group (LSAG). “We work hard to create innovative solutions to meet the evolving needs of our customers—particularly the need to simplify their workflows, improve productivity, and reap the benefits of greater connectivity. These awards are a recognition of our continued investment in research and development for the future of the laboratory.”

Both Agilent systems integrate next-generation intelligence, including diagnostic tools and software that ensure pro-active maintenance for maximum uptime and greater sample throughput.

The award for the 8890 reflects the value chromatographers see in these state-of-the-art smart connected technologies. Combined with the system’s flexible configurability, the 8890 is able to meet chromatographic needs today and well into the future.

This is the third award for the InfinityLab LC/MSD iQ system since launching in 2019, a reflection of how the system’s ease of use makes LC/MS technology accessible to chromatographers. The system has previously been recognized by The Analytical Scientist and The Medicine Maker 2019 Innovation awards.

Winners were announced at Pittcon 2020, the world’s largest annual conference and exposition on laboratory science, in Chicago, Illinois.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Catherine Kaye
Agilent Technologies
+447775 410632
catherine.kaye@agilent.com

More News From Agilent Technologies Inc.

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company’s expanding capabilities across Canada and the United States. Agilent Advanced Therapeutics brings together the strengths of BIOVECTRA in Canada and Nucleic Acid Solutions in Colorado to deliver a full suite of premium, scalable and customizable manufacturing so...

Agilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology Solutions

SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit...

Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today reported revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% core(1) compared with the first quarter of 2025. First-quarter GAAP net income was $305 million, or $1.07 per share. This compares with $318 million, or $1.11 per share, in the first quarter of 2025. Non-GAAP(2) net income was $386 million, or $1.36 per share, during the quarter, compared wi...
Back to Newsroom